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Long-chain acyl-CoA esters are key metabolites in lipid synthesis
and b-oxidation but, at the same time, are important regulators
of intermediate metabolism, insulin secretion, vesicular traffick-
ing and gene expression. Key tools in studying the regulatory
functions of acyl-CoA esters are reliable methods for the de-
termination of free acyl-CoA concentrations. No such method is
presently available. In the present study, we describe the synthesis
of two acyl-CoA sensors for measuring free acyl-CoA concentra-
tions using acyl-CoA-binding protein as a scaffold. Met#% and
Ala&$ of bovine acyl-CoA-binding protein were replaced by
cysteine residues, which were covalently modified with 6-bromo-
acetyl-2-dimethylaminonaphthalene to make the two fluorescent
acyl-CoA indicators (FACIs) FACI-24 and FACI-53. FACI-24
and FACI-53 showed fluorescence emission maximum at 510 and
525 nm respectively, in the absence of ligand (excitation
INTRODUCTION
Non-esterified fatty acids (NEFAs) with acyl chains " 16 carbons
are quantitatively the most important physiological energy
source. By supplying 60–70% of cardiac energy requirement,
circulating fatty acids represent the major energy source for
cardiac tissue. The concentration of NEFAs in circulating blood
is the rate determining factor in the regulation of fatty acid
uptake [1] and has been shown to affect intracellular acyl-
CoA concentrations [2]. Conversion of fatty acids into their CoA
thioester derivatives is an obligatory step in the utilization of
fatty acids for b-oxidation, complex lipid synthesis and post-
translational protein modification. However, besides playing a
key role in lipid metabolism, acyl-CoA esters have also been
shown to act as regulators of enzyme activities, vesicular traffick-
ing, hormone signalling, Ca#+ fluxes, ion channels and gene
transcription (see [3] for review).
By influencing the circulating fatty acid levels and composition,
dietary fatty acids specifically modulate the onset of various
diseases, including cancer [4–6], atherogenesis [7] and coronary
heart disease [8]. A still growing number of scientific reports
indicate that accumulation of both intramuscular triacylglycerol
and long-chain acyl-CoA (LCA) esters strongly correlate with
the development of insulin resistance [9,10]. Defects in insulin
Abbreviations used: ACBP, acyl-CoA-binding protein ; ADIFAB, acrylodated intestinal fatty acid-binding protein ; DTT, dithiothreitol ; FABP, fatty acid-
binding proteins ; FACI, fluorescence acyl-CoA indicator ; LCA, long-chain acyl-CoA; NEFA, non-esterified fatty acid ; TCA, trichloroacetic acid.
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387 nm). Titration of FACI-24 and FACI-53 with hexadecanoyl-
CoA and dodecanoyl-CoA increased the fluorescence yield 5.5-
and 4.7-fold at 460 and 495 nm respectively. FACI-24 exhibited
a high, and similar increase in, fluorescence yield at 460 nm upon
binding of C
"%
–C
#!
saturated and unsaturated acyl-CoA esters.
Both indicators bind long-chain ("C
"%
) acyl-CoA esters with
high specificity and affinity (K
d
fl 0.6–1.7 nM). FACI-53 showed
a high fluorescence yield for C
)
–C
"#
acyl chains. It is shown that
FACI-24 acts as a sensitive acyl-CoA sensor for measuring the
concentration of free acyl-CoA, acyl-CoA synthetase activity
and the concentrations of free fatty acids after conversion of the
fatty acid into their respective acyl-CoA esters.
Key words: diagnostics, dissociation constant, intestinal fatty
acid-binding protein.
function caused by tissue-specific expression of lipoprotein lipase
[11] and high fat feeding in rat are closely associated with
accumulation of LCA [12]. A strong inverse correlation between
glucose uptake and LCA content is observed in red quadriceps
[13,14], and LCA content in human skeletal muscle correlates
well with the measurement of whole body insulin action [12].
These observations have led to the suggestion that an initial
increase in the content of LCA might be the primary event
leading to insulin resistance. Increased levels of fatty acids and
LCA have also been suggested to play an important role in both
regulating insulin secretion and impaired b-cell function in late
stages of type II diabetes [15,16].
LCA esters are highly amphiphatic molecules which bind non-
specifically to proteins, test tube walls and partition into lipid
membranes (Kfl 1.5‹10&) [17]. The concentration of unbound
acyl-CoA esters, which are presumed to be the regulatory species,
is therefore likely to be different from the total concentration.
Determination of free LCA concentrations in io and in itro
therefore have important applications in a wide variety of
biochemical, biophysical, cell biological and physiological in-
vestigations. A number of HPLC, GLC and enzymic methods
for determination of total acyl-CoA levels in tissue extracts and
body fluids have been developed (see [18] for review). NEFA
concentrations can conveniently be determined using the acrylo-
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dated intestinal fatty acid-binding protein (ADIFAB) [19]. How-
ever, a similar method is not currently available for determining
free acyl-CoA levels. In the present study, we describe the
construction and synthesis of a fluorescent acyl-CoA-binding
protein (ACBP), which is capable of determining free acyl-CoA
concentrations, monitoring the activity of acyl-CoA-producing
enzymes and acts as a convenient sensor for the determination of
NEFAs, provided that they are converted into acyl-CoA esters
by an acyl-CoA synthetase.
MATERIALS AND METHODS
Reagents
Badan (6-bromoacetyl-2-dimethylaminonaphthalene) was ob-
tained from Molecular Probes (Eugene, OR, U.S.A.). CoA was
obtained from ICN Biomedicals (Costa Mesa, CA, U.S.A.). The
plasmid pN3576 carrying the gene encoding the Escherichia coli
acyl-CoA synthetase FadD was kindly provided by Dr Paul
Black, Albany Medical College, Albany, NY, U.S.A. FACI-24
was obtained from Biosensor ApS (AI rslev, Denmark). All other
reagents used were of analytical grade.
Site-directed mutagenesis and protein expression and purification
Site-directed mutagenesis of recombinant bovine ACBP was
performed as described previously [20]. Briefly, adjacent 5«-
phosphorylated oligonucleotides were designed on opposite
DNA strands with the mutation encoded at the 5«-end of the
upstream primer. PCR mutagenesis was performed by using
the bovine ACBP open reading frame in pET3a as a template
(10–50 ng) in a mixture consisting of 1.25 units of Pfu turbo
polymerase (Stratagene, La Jolla, CA, U.S.A.), 50 pmol of each
oligonucleotide and 200 lM of each dNTP in Pfu reaction buffer
[20 mM Tris}HCl (pH 8.8), 10 mM KCl, 10 mM (NH
%
)
#
SO
%
,
2 mM MgSO
%
, 0.1% Triton X-100 and 10 lg}ml BSA]. The
primers used for amplification of individual mutants are shown
in Table 1. Prior to amplification, the template was denatured at
94 °C for 5 min, followed by 16 cycles of 94 °C for 1 min, 55 °C
for 1 min, and 72 °C for 13 min. Controls did not receive any
polymerase. Subsequently, the amplicon was extracted in phe-
nol}chloroform}isoamyl alcohol (25:24:1, by vol.) and precipi-
tated with ethanol. DNA was resuspended in 20 ll of T4 ligase
buffer (New England Biolabs, Frankfurt, Germany) containing
T4 ligase (10 units) and incubated for 18 h at 16 °C. The samples
were diluted to 50 ll in DpnI digestion buffer [50 mM potassium
acetate, 20 mM Tris acetate, 10 mM magnesium acetate and
Table 1 Primers used for site-directed mutagenesis of bovine ACBP
Underlined bases represent the location of the mutated bases.
Mutation Sequence
Met24Cys
Upstream 5«-TGCTTGTTCATCTACTCTCACTACAAG
Downstream 5«-TTCTTCGTCGGCCGGCTTGGTCTTC
Met46Cys
Upstream 5«-TGCTTGGACTTCAAGGGTAAGGCTAAG
Downstream 5«-CCCGGGTCTTTCGGTGTTGATGTC
Phe49Cys
Upstream 5«-TGCAAGGGTAAGGCTAAGTGGGACGCT
Downstream 5«-GTCCAACATCCCGGGTCTTTCGGT
Ala53Cys
Upstream 5«-TGCAAGTGGGACGCTTGGAACGAATTG
Downstream 5«-CTTACCCTTGAAGTCCAACATCCC
1 mM dithiothreitol (DTT) (pH 7.9)] and incubated with DpnI
(60 units) for 2 h at 37 °C. DNA (2–5 ll) was then transformed
into CaCl
#
-competent DH5a cells. Plasmid DNA was isolated by
standard methods and plasmids carrying the correct change were
identified by restriction analysis and DNA sequencing.
For large-scale production of recombinant protein, the bacteria
were grown in a 4 litre fermenter as described previously [21].
The cells were harvested by centrifugation and frozen at fi80 °C.
Cells were thawed, resuspended in 0.9% NaCl}1 M acetic acid,
sonicated and cleared by centrifugation for 20 min at 10000 g at
4 °C. The pH was adjusted to 7.0 with 1 M NaOH and the
precipitated proteinswere removed by centrifugation as described
above. The cleared supernatant (approx. 140–160 ml) was divided
in two and was loaded on to a Sephadex-G50 column (5 cm‹
80 cm; Amersham Biosciences, Copenhagen, Denmark), equili-
brated and run with 10 mM Tris}HCl (pH 7.2) at 72 ml}h. The
eluate was collected in 12 ml factions. The fractions containing
the ACBP peak were pooled, diluted to 5% (w}v) with freshly
prepared 50% (w}v) trichloroacetic acid (TCA) and centrifuged
as described above. The tube walls and the protein pellet were
washed carefully with 10 mM TCA. The residual TCA was
removed carefully and the protein pellet was dissolved in 30 mM
Tris base}100 mM DTT and the pH adjusted to 7.2 with
30 mM Tris base. The solution was cleared by centrifugation and
stored at fi80 °C. Immediately before badan labelling, the frozen
supernatant was thawed and loaded on to a Q-Sepharose HP
column (1.5 cm‹12 cm; Amersham Biosciences), pre-equili-
brated with buffer A [10 mM Tris}HCl (pH 7.2)], and bound
proteins were eluted with a linear gradient from 0–100% buffer
B [400 mM NaCl in 10 mM Tris}HCl (pH 7.2) ; equivalent to a
gradient of 0–400 mM NaCl], with a flow of 3 ml}min. The
fractions containing ACBP were pooled, adjusted to a con-
centration of 100 mM with 1 M Tris}HCl (pH 7.2) and used
directly for synthesis of badan-derivatized ACBP.
Badan labelling
The bovine recombinant Met#%Cys-, Met%’Cys-, Phe%*Cys- and
Ala&$Cys-ACBPs were labelled with badan. Synthesis and hand-
ling of badan-derivatized proteins was carried out under dim
light. To carry out the reaction, 1.1-fold molar excess of badan
to ACBP was added over 10 min by continuous infusion from a
20 mMstock solution of badan (dissolved in dimethylformamide)
to a 5 mg}ml solution of the individual proteins. The progress of
the reaction was monitored by HPLC by injection of aliquots on
to a Jupiter C
")
reverse-phase column [5 lm particle size, 300 AI
pore size (1 AI fl 0.1 nm), 4.6 mm‹250 mm; Phenomenex,
Aschaffenburg, Germany] pre-equilibrated with buffer C (20%
acetonitrile in water}0.05% TFA). Elution was carried out using
a gradient from 15–100% buffer D (80% acetonitrile in water}
0.05% TFA; equivalent to 20–80% acetonitrile) over a period of
15 min. Badan infusion was continued until all non-derivatized
ACBP had disappeared. The reaction was then stopped by the
addition of 1 mM DTT, and the reaction mixture was desalted
into water on a Sephadex-G25 column (5 cm‹25 cm) and freeze-
dried. The location of the badan-derivatized amino acid was
confirmed by tryptic digestion and separation of the tryptic
peptides by reverse-phase HPLC using a water}acetonitrile}TFA
solvent system, followed by mass determination and sequencing
of the fluorescently labelled peptide. The resulting fluorescent
acyl-CoA indicators (FACIs) were named FACI-24 (Met#%Cys-
ACBP–badan), FACI-46 (Met%’Cys-ACBP–badan), FACI-49
(Phe%*Cys-ACBP–badan) and FACI-53 (Ala&$Cys-ACBP–
badan) respectively, to signify the modified amino acid residue.
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Acyl-CoA titration of FACI
Titration of FACIs with acyl-CoAs was performed using a SPEX
FLOUROLOG (SPEX Industries Inc, Edison, NJ, U.S.A.) with
excitation at 387 nm and emission at 460 nm, and both excitation
and emission slits set to 4.5 nm. FACI (0.5–4.5 lM, as indicated)
was dissolved in 1.5 ml of binding buffer [10 mM Hepes, 150 mM
NaCl, 5 mM KCl and 1 mM Na
#
HPO
%
(pH 7.4)] and titrated
with 10 lM acyl-CoA dissolved in binding buffer, with or without
FACI added, as indicated. Fluorescence emission values (counts
per second) measured without FACI added to the ligand stock
solution were corrected for titrant dilution.
Equilibrium binding analysis
The development of a mathematical equation describing the
relationship between acyl-CoA concentration and FACI-24
fluorescence was performed essentially as described previously
[19]. However, where ligand binding to ADIFAB induces both a
fluorescence intensity increase at approx. 505 nm and a fluor-
escence intensity decrease at approx. 432 nm, ligand binding to
FACI-24 only causes an increase in fluorescence at approx.
460 nm. Hence, the equation describing the relationship between
the free concentration of acyl-CoA and the fluorescence is :
[acyl-CoA]flK
d
FfiF
min
F
max
fiF
(1)
where F is the fluorescence intensity at 460 nm and
[acyl-CoA
bound
]fl [FACI]
FfiF
min
F
max
fiF
min
(2)
The derivation of an expression for the fluorescence value as a
function of the acyl-CoA concentration was performed using the
Scatchard equation as a starting point :
1
[acyl-CoA
bound
]
fl
K
d
[FACI]
[acyl-CoA]
›
1
[FACI]
(3)
Since [acyl-CoA
free
]fl [acyl-CoA
total
]fi[acyl-CoA
bound
] and re-
calling eqn 2:
1
[acyl-CoA
bound
]
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This equation can be solved for F, yielding
F fl
(F
max
fiF
min
)oK #
d
›(2[acyl-CoA]›2[FACI])K
d
›[acyl-CoA]#fi2[FACI][acyl-CoA]›[FACI]#›(F
max
fiF
min
)K
d
›(fi[acyl-CoA]fi[FACI])F
max
›([acyl-CoA]fi[FACI])F
min
2[FACI]
(4)
This equation has been used to fit the titration data.
Titration data analysis
Fluorescence emission intensity is presented as a function of the
acyl-CoA:FACI-24 ratio, and fitted to the mathematical model
(described by eqn 4) using DataFit2 7.1 software (Oakdale
Engineering, Oakdale, PA, U.S.A.). Four parameters were fitted,
namely the point of acyl-CoA}FACI equimolarity (B ), initially
set to 1, the maximum fluorescence emission intensity (F
max
), the
minimum fluorescence emission intensity (F
min
) and the K
d
value
for the acyl-CoA. For each acyl-CoA, at least two titrations and
fittings were performed. To compare two or more titrations of
the same acyl-CoA together and obtain a K
d
value, both axes
of the raw data were normalized using the fitted values of B, F
max
and F
min
in this way: X axis standardfl (raw X axis values)}B
fitted; and Y axis standardfl [(raw Y axis values)fiF
min
fitted]}[
F
max
fittedfiF
min
fitted].
The normalized data were fitted using DataFit2. For short-
chain (!C
)
:
!
-CoA) acyl-CoA esters, titration curves were found
to lack a significant point of saturation, causing the fitting
procedure to yield very high B values (2–3). This could be
overcome by removing B from the list of parameters to be fitted,
and instead setting it to a constant value of 1 and fitting again.
This was done for both the raw and the standardized data.
Determination of acyl-CoA synthetase activity and quantification
of NEFA concentration
Determination of acyl-CoA synthetase activities and the
concentration of free NEFAs were performed in black 96 multi-
well plates using a Wallac Victor# Multilabel Reader (Wallac
Oy, Turku, Finland). The reaction mixture (200 ll) contained
3 lM FACI-24 in 200 mM Tris}HCl (pH 7.4), 1 mM DTT, 2 mM
EDTA, 4 mM MgCl
#
, 4 mM ATP, 60 lM CoA, 0.03 unit}ml
acyl-CoA synthetase (GST–FadD) and 3 lM BSA. NEFA
standard solutions were made as follows: fatty acids (1.26 lmol),
dissolved in 1 ml of ethanol, were neutralized with equimolar
amounts of 0.1 M NaOH and diluted with 4 ml of 96% ethanol
to give a final concentration of 252 lM. The stock solution was
diluted with 96% ethanol and added in 5 ll portions to the final
reaction mixture in the multi-well microtitre plates. The plates
were covered with parafilm and aluminium foil and allowed to
incubate on an orbital shaker for 2 h at 20 °C. Fluorescence
emission was measured at 460 nm (excitation at 390 nm) using a
Wallac Victor# Multilabel Reader.
Production of GST–FadD
Recombinant E. coli fatty acyl-CoA synthetase FadD was
expressed as an N-terminal GST fusion protein. The open reading
frame of FadD was amplified using the pN3576 plasmid as a
template [19] and specific oligonucleotides 5«-CACGGATCCAT-
GAAGAAGGTTTGGCTTAACC-3« and 5«-CACGAATTCT-
CAGGCTTTATTGTCCACTTTG-3«, carrying either a BamHI
or EcoRI restriction site (underlined) respectively. The Expand
High Fidelity PCR System was used as described by the
manufacturer (Roche, Hvidovre, Denmark). The PCR product
was digested with EcoRI and BamHI and ligated into the pGEX-
2TK vector (Amersham Biosciences) using standard techniques.
The recombinant GST fusion protein was expressed in the E. coli
BL21(DE3)pLysS strain and purified essentially as described by
the manufacturer (Amersham Biosciences), except that CoA
(10 mM) was included in all buffers including the elution buffer.
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Figure 1 Bovine ACBP/C16:0-CoA tertiary structure
ACBP is shown as backbone, the CoA head group (grey, ball-and-stick) and the acyl chain (grey, spacefill). The modified residues, Met24 (M24 ; red), Met46 (M46 ; yellow), Phe49 (F49 ; magenta)
and Ala53 (A53 ; blue) are highlighted with ball-and-stick models. The positions of a-helices (A1, A2, A3 and A4) are also indicated. C-term, C-terminus ; N-term, N-terminus.
Figure 2 Q-Sepharose HP ion-exchange separation of bovine Met24Cys-
ACBP derivatives
The TCA-precipitated protein was dissolved in Tris-base and pH adjusted to 7.2 and loaded on
to a Q-Sepharose HP column (1.5 cm‹12 cm) pre-equilibrated with buffer A. Proteins were
eluted with a gradient of 0–100% buffer B at a flow rate of 3 ml/min. See Materials and methods
section for further details. Solid line, A280 ; dashed line, percentage of buffer B.
RESULTS
Protein expression and modification
Since fatty acid-binding proteins (FABPs) binds both fatty acids
and acyl-CoA esters, the fluorescently labelled FABP ADIFAB
cannot be used to measure the formation of acyl-CoA esters
from NEFAs, because both ligands will generate a fluorescence
emission upon binding. The advantage of using ACBP as a
scaffold for making an acyl-CoA sensor is its very high specificity
and affinity for acyl-CoA esters. Native bovine ACBP does not
Figure 3 Analysis of FACI-24 by reverse-phase HPLC
The desalted reaction product from synthesizing FACI-24 was analysed on a Jupiter C18 reverse-
phase column [5 lm particle size, 300 AI pore size (1 AI fl 0.1 nm), 4.6 mm‹250 mm] pre-
equilibrated with buffer C and eluted with a gradient from 15–100% buffer D as shown. The
results show that the product only contains one species and that the A280- (dashed line) and
A387- (solid line) absorbing materials co-elute.
contain any cysteine residues. The strategy behind the design of
an acyl-CoA sensor was to replace selected amino acid residues
with cysteine residues and subsequently modify this residue using
the thiol-reactive fluorescent probe badan. Met#% and Ala&$,
which interact with carbons 12–16 of hexadecanoyl-CoA, and
Phe%*, positioned at the bottom of the binding pocket interacting
with the X-methyl group of this ligand [22], were chosen for
modification (Figure 1). Positioning of an environmentally
sensitive group in one of these positions would therefore be
expected to create ligand-sensitive probes. Met%’, which is located
outside the hydrophobic binding pocket in the loop between
helix 2 and 3, was chosen as a negative control, which should not
be sensitive to ligand binding. Expression of the cysteine-modified
bovine ACBPs in E. coli DH5a with the gene inserted in the
pKK233-3 expression vector, as described previously for native
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Figure 4 Fluorescence emission spectra (A and B) and fluorescence emission intensity dependence of acyl-CoA chain length (C and D) for FACI-24 (A and
C) and FACI-53 (B and D)
Fluorescence emission spectra from titration of FACI-24 with C16-CoA (A) and FACI-53 with C12-CoA (B). Ligand concentrations were 0 (+), 0.3 (E), 0.6 (_), 0.9 (U), 1.2 (‹), 1.8 (*),
2.7 (D) and 3.3 (^) lm hexadecanoyl-CoA and dodecanoyl-CoA respectively. Acyl-CoA chain-length dependence of fluorescence emission maximum for FACI-24 (C) and FACI-53 (D) at saturating
ligand concentrations. Excitation was at 387 nm and emission at 460 nm. For experimental details see Materials and methods section.
ACBP, was unsuccessful (J. Knudsen, unpublished work).
The bacteria grew very slowly or expressed only low levels of the
cysteine-modified ACBP proteins, indicating that they were toxic
to DH5a. Expression of the cysteine-containing proteins from
the pET3a vector in the E. coli strain BL21(DE3)pLysS resulted
in a high yield of recombinant proteins. However, following
purification we found that the introduced cysteine residue was
partially modified, a phenomenon which was most pronounced
with Ala&$Cys-ACBP. Approx. 50% of the Ala&$Cys-ACBP
produced was esterified with CoA, as shown by MS (result not
shown). The expressed Met#%Cys-ACBP contained two modified
versions that could be separated from the unmodified form by Q-
Sepharose ion-exchange chromatography (Figure 2). The final
unmodified product was shown to have the correct molecular
mass as determined by MS (9883 Da; results not shown). Wild-
type recombinant bovine ACBP did not react with badan under
the reaction conditions used (results not shown); however,
modification of the cysteine residue in Met#%Cys-ACBP caused a
second group to react with badan. To prevent modification of
this group, a 1.1-fold molar excess of badan to Met#%Cys-ACBP
was infused into the reaction mixture at a controlled rate. Using
this procedure, the Met#%Cys-ACBP was found to be completely
modified to give only one product (Figure 3). The small amount
of double-derivatized protein was insoluble and was completely
absorbed during desalting. MS showed that the final product
only contained one protein species with a molecular mass of
10095 Da, confirming that Met#%Cys-ACBP had only been
modified with one badan. Tryptic digestion of FACI-24 resulted
in two badan-derivatized peaks with molecular masses of 2155.71
and 1865.26 Da respectively. The unmodified tryptic peptide
Thr"(–Lys$# of Met#%Cys-ACBP has a predicted molecular mass
of 1943.19 Da. The molecular masses of the two peaks, corrected
for the badan group (211.09 Da), are 1944.62 and 1654.17 Da
respectively. The 2155.71 Da peptide therefore corresponds to
the Thr")–Lys$# peptide, and the 1865.26 Da peptide is the same
peptide which has lost the C-terminal Thr$" and Lys$#. These
data confirm that FACI-24 is derivatized with one badan at
position Cys#%. The Ala&$Cys-ACBP variant eluted as two
completely separate peaks from the ion-exchange column. MS
showed that the second peak was 767 mass units larger, cor-
responding to the molecular mass of CoA. As expected, this
extra mass could be removed by incubation with 100 mM DTT.
This indicates that 30–40% of Cys&$ in Ala&$Cys-ACBP was
covalently modified with CoA, through a disulphide bridge, by
E. coli. Met%’Cys- and Phe%*Cys-ACBP were both determined to
have the correct molecular mass. Their badan derivatives FACI-
46, FACI-49 and FACI-53 was synthesized and characterized as
described for FACI-24 above.
Ligand binding
Fluorescence titration emission spectra from 415–550 nm (ex-
citation at 390 nm) were performed for CoA, C
%
:
!
-, C
)
:
!
-, C
"#
:
!
-,
C
"’
:
!
- and C
#!
:
!
-CoA with all four mutated and badan-modified
proteins. FACI-46 and FACI-49 did not show any emission
spectra changes with any of the ligands (results not shown) and
were therefore not investigated further.
Titration of FACI-53 dissolved in binding buffer with the
above-mentioned acyl-CoA esters produced a smooth downward
shift in fluorescence emission maximum from 525 nm when no
ligand was present to 508, 503, 490, 492, 496 and 514 with
increasing concentrations of CoA, C
%
:
!
-, C
)
:
!
-, C
"#
:
!
-, C
"’
:
!
- and
C
#!
:
!
-CoA respectively (results not shown). Titration with C
"’
:
!
-
CoA is shown in Figure 4(B). The magnitudes of emission at
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Figure 5 Normalized fitted binding curves for titration of FACI-24 with C8:0-,
C12:0- and C16:0-CoA
FACI-24 [1 lM in 10 mM Hepes/150 mM NaCl, 5 mM KCl/1 mM NaH2PO4 (pH 7.4)] was
titrated with increasing amounts of C8 :0-CoA (U), C12 :0-CoA (+) or C16 :0-CoA (_) in the
above buffer. Fluorescence values were adjusted for titrant dilution and mathematically fitted
(see Materials and Methods section). Saturation degree (ratio of acyl CoA–FACI-24 complex
to total FACI-24) was calculated from eqn 2. Results show an overlay of two independent
titrations with each ligand.
Table 2 Dissociation constants for binding of CoA and acyl-CoA esters to
FACI-24
FACI-24 (1.5 lM) was titrated with increasing CoA and acyl-CoA concentrations as shown in
Figure 5. The data were fitted and Kd calculated as described in the Materials and method
section. Results are means‡S.E.M.
Ligand Kd (nM)
CoA 2448.70‡248.60
C4:0-CoA 1496.80‡222.60
C8:0-CoA 342.00‡31.90
C10 :0-CoA 61.80‡2.40
C12 :0-CoA 10.20‡0.81
C14 :0-CoA 1.66‡0.26
C16 :0-CoA 0.65‡0.26
C18 :0-CoA 1.65‡0.83
C18 :1-CoA 0.59‡0.19
495 nm were increased 1.1-, 1.8-, 4.8-, 4.7-, 2.2- and 0.8-fold
(Figure 4D), in the same order, demonstrating that FACI-53
gives the strongest signal for C
)
:
!
- to C
"#
:
!
-acyl chains.
The emission maximum of FACI-24 without ligand added was
510 nm and titration with CoA, C
%
:
!
-, C
)
:
!
-, C
"#
:
!
-, C
"’
:
!
- and
C
#!
:
!
-CoA resulted in a 0, 16, 34, 42, 46 and 46 nm downshift in
emission maximum respectively (results not shown). C
"’
:
!
-CoA
induced a 5.5-fold increase in emission at 464 nm (Figure 4A).
Titration of FACI-24 with increasing concentrations of C
)
:
!
-,
C
"#
:
!
- and C
"’
:
!
-CoA resulted in a gradual increase in emission
fluorescence at 460 nm (Figure 5), providing a sensitive measure
for acyl-CoA binding. The curves represent the best-fit analysis
from two independent experiments calculated and normalized as
described above. The dissociation constants (K
d
) for binding of
the individual ligand to FACI-24 calculated from the binding
curves are listed in Table 2. The FACI-24-binding affinity
increased dramatically when the length of the acyl chain increased
from C
)
to C
"!
and C
"#
, whereas a smaller, but significant, drop
in K
d
is seen by increasing chain length from C
"#
to C
"%
. C
"%
- to
C
")
-saturated acyl-CoA esters and C
")
:
"
-CoA binds with similar
and very high affinities to FACI-24. FACI-24 binds acyl-CoAs
Figure 6 Determination of GST–FadD activity using FACI-24 as a sensor
for the rate of acyl-CoA formation
The reaction mixture (1.5 ml) contained 3 lM FACI-24 in 200 mM Tris/HCl (pH 7.4), 1 mM
DTT, 2 mM EDTA, 4 mM MgCl2, 4 mM ATP, 60 lM CoA, 0.03 unit/ml acyl-CoA synthetase
(GST–FadD), 3 lM BSA and 100 lM sodium palmitate. The reaction was followed by
monitoring the increase in emission at 460 nm (excitation 387 nm) over time.
with similar affinity and specificity as native unmodified bovine
ACBP. The K
d
for binding of C
"#
:
!
- and C
"’
:
!
-CoA to native ACBP,
as determined by isothermal titration microcalorimetry in 25 mM
ammonium acetate (pH 6.0), is 5.0 and 2.0 nM respectively
[23,24]. FACI-24 is highly specific for binding LCA esters ;
however, NEFAs do not bind and do not affect fluorescence
emission at any wavelength (results not shown). FACI-24 binds
free CoA with a similar low affinity (K
d
fl 2.5 lM) as native
bovine ACBP (K
d
fl 2 lM; [25]). CoA induces a smaller increase
(3-fold) in FACI-24 fluorescence emission at 470 nm than C
"%
:
!
-
to C
")
:
!
-CoA, which induce 5- to 6-fold increases in fluorescence.
The relative emission change induced by binding CoA and C
#
- to
C
")
:
!
-CoA to FACI-24 are shown in Figure 4(C).
The shift in the fluorescence emission maximum from 525 nm
to 460 nm upon ligand binding indicates that the badan group is
shifted from a more hydrophilic environment to a more hydro-
phobic environment [4]. The precise mechanism of interaction of
the ligand with the badan group is unknown. However, the fact
that the interaction of C
"#
:
!
- to C
")
:
!
-CoA esters results in very
similar increases in the emission yield at 460 nm independent of
the length of the acyl chain, indicates that it is either the early
part of the acyl chain or the CoA head group which interacts
with the badan group. This interpretation is supported by folding
studies which suggest that the pantetheine part of the CoA head
group interacts with the acyl chain of hexadecanoyl-CoA bound
to native bovine ACBP [4]. The final evidence for this interaction
will have to await determination of the tertiary structure of apo
and holo FACI-24, which is currently in progress.
The very high fluorescence yield and binding affinity for acyl-
CoAs with a length of the chain "C
"#
:
!
-CoA (K
d
fl 1–2 nM),
combined with the low binding affinity (K
d
fl 2 lM) and low
fluorescence yield with CoA, makes FACI-24 a potential sensor
for quantification of mixtures of C
"#
:
!
- to C
#!
:
!
-CoA esters
synthesized by acyl-CoA synthetase.
Measurement of acyl-CoA synthetase activity
The activity of the fatty acyl-CoA synthetase FadD was followed
by measuring the increase in the fluorescence intensity at 460 nm
in a cuvette with reaction mixture containing FACI-24 and
GST–FadD (Figure 6). The results show that emission at 460 nm
increased in a linear fashion over time. The addition of the
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Figure 7 Fatty acid standard curve
Various concentrations of sodium palmitate (FA), dissolved in ethanol (5 ll), were added to
200 ll of reaction mixture [200 mM Tris/HCl (pH 7.4), 1 mM DTT, 2 mM EDTA, 4 mM MgCl2,
4 mM ATP, 60 lM CoA, 0.03 unit/ml acyl-CoA synthetase (GST–FadD) and 1 lM BSA]
containing 1 lM FACI-24 and the fluorescence yield (in counts per second, cps) was
determined as described in the Materials and methods section. Results are means‡S.D. The
equation of the fitted line is indicated along with the correlation coefficeint (R 2 ).
reaction mixture increased background fluorescence; however,
this did not affect the sensitivity of the sensor.
Incubating GST–FadD in reaction mixture containing FACI-
24 (1.0 lM) and increasing sodium palmitate concentrations
(Figure 7) showed that FACI-24 produced an almost linear
increase in emission at 460 nm in response to the increased
concentration of NEFAs in the reaction mixture. This suggests
that FACI-24 might be used for establishing a very simple and
highly sensitive assay for determining NEFA concentrations in
biological fluids and tissue extracts.
DISCUSSION
LCA esters are not only key metabolites in lipid synthesis and b-
oxidation, but also important regulators of metabolism, insulin
secretion, vesicular trafficking and gene expression [3]. A finely
tuned balance between the activities of acyl-CoA synthetases and
hydrolases control the free acyl-CoA concentrations. Specialized
ACBPs are believed to channel acyl-CoA to their site of action. A
key tool in the study of the regulatory functions of acyl-CoA
esters is a reliable method for the determination of free acyl-
CoA concentrations. However, no method is presently available
for measuring free acyl-CoA concentrations. In the current study,
we present the synthesis of two acyl-CoA sensors for measuring
free acyl-CoA concentrations, using ACBP as a scaffold.
The present results demonstrate that bovine ACBP provides a
useful scaffold for synthesizing acyl-CoA sensors with different
specificity. The fluorescence emission yield of FACI-53 is
highly specific for C
)
:
!
- to C
"#
:
!
-CoAs. FACI-24 provides an all-
round acyl-CoA sensor for measuring low concentrations of free
acyl-CoAs with chain lengths longer than 14 carbon atoms.
Determination of binding constants for high affinity ACBPs
(K
d
! 10 nM) is difficult by conventional techniques, such as
isothermal titration microcalorimetry [3]. This problem can now
be overcome with FACI-24 by using the approach adopted by
Kleinfeld and co-workers [19] for determining binding constants
for FABPs using fluorescently labelled ADIFAB. Using the same
experimental approach, FACI-24 provides an excellent tool for
determining binding affinities for ACBPs with K
d
s in the low
nanomolar range. We have shown previously that the K
d
for
binding of hexadecanoyl-CoA to bovine ACBP gradually in-
creased from 2–1500 nM by successively mutating Lys$# to
arginine, alanine and glutamic acid respectively [22]. We are
currently making FACI-24 carrying these changes to produce
FACIs covering the binding affinity range from 0.5 nM–4 lM.
The results from measuring FadD activity show that FACI-24 is
an excellent sensor for the determination of the activity of acyl-
CoA-producing enzymes. FACI-24 binds C
"%
–C
")
saturated and
unsaturated acyl-CoA esters with similar affinity and fluorescent
emission yield at 460 nm. This suggest that FACI-24 might be
used as a convenient and sensitive sensor for quantification of
NEFAs in biological fluids, after conversion of the acids into
acyl-CoA esters.
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